Go to content Go to the menu Go to the search

DIM: Health, Environment and Toxicology

Quick access, personalized services

Search

Advanced search

DIM: Health, Environment and Toxicology

There are 16 DIM (Fields of Major Interest) identified by the Île-de-France region according to three different types:

- Prospective fields: ultra-cold atoms, natural complex systems (the brain, living things) and artificial complex systems (towns, technology).

- Social fields: economic sciences, public health and epidemiology, gender issues (questions as to the social organisation or relationships between women and men).

- Fields known as ‘clusters’, that can be found in the ‘competitiveness clusters’ of the Île-de-France region (these are associations in France of companies/institutions that cooperate on innovative projects intended to increase the competitiveness of a given market): cancerology, neurosciences, neurodegenerative diseases, molecular medicine, microbiology, medical imaging, optics, software and complex systems, sustainable development. Microelectronics and the nanosciences have been part of these since June 2006. In October 2007, three new fields in the life sciences were added – cellular medicine and stem cells, the cardiovascular system, diabetes and obesity and, finally, emerging infectious, parasitic and nosocomial diseases. In April 2008, two new DIMs were approved – the first involves health, the environment and toxicology, and the second is known as ‘Agrosciences, Land, Ecology, Food’. The research topics involved in the DIM ‘Health, Environment and Toxicology’ will be individual vulnerability in relation to environmental risk, the impact of physical, chemical, climatic and biological aggression on human health, predictive toxicology and the emerging risks. The network working on these topics will bring together research teams from higher education teaching establishments in the Île-de-France region such as, notably, the universities Paris-Descartes (Paris-V), UPMC (Paris-VI), Paris-Diderot (Paris-VII) and Paris-Sud (Paris-XI) as well as the National Institute of Health and Medical Research (INSERM) and the National Centre for Scientific Research (CNRS).



06/11/08